HCA Healthcare reports third-quarter revenue growth for HCA Healthcare stock - ad-hoc-news.de
Article excerpt
Highlighted: the sentence this signal was extracted from
HCA Healthcare (ISIN US40412C1018) reported third-quarter 2026 revenue of USD 19.849 billion on October 27, 2026, up 3.6 percent from USD 19.161 billion in the prior-year quarter, according to HCA Healthcare. HCA Healthcare was trading at EUR 400.90 at Lang & Schwarz on October 27, 2026 at 4:12 p.m. CEST. Net income attributable to HCA Healthcare declined 3.9 percent to USD 1.579 billion in the third quarter, while diluted earnings per share increased 4.5 percent to USD 7.27. Adjusted diluted earnings per share rose 3.7 percent to USD 7.22, and adjusted EBITDA increased 1.2 percent to USD 3.918 billion, according to the company release dated October 27, 2026. The operating picture was uneven. Same-facility admissions increased 2.7 percent and emergency room visits rose 5.1 percent, but same-facility inpatient surgeries declined 1.4 percent and outpatient surgeries fell 3.7 percent during the third quarter. The payer mix shift caused by higher uninsured volume reduced pretax income by approximately USD 400 million in the third quarter, Becker's Hospital Review reported on October 27, 2026. That pressure helps explain why revenue growth did not translate into higher GAAP net income. HCA reported USD 4.461 billion in operating cash flow for the third quarter and USD 50.493 billion in total debt as of September 30, 2026. The company repurchased 7.230 million shares for USD...
Keep reading with a free account
The rest of this article, and every signal for HCA Healthcare, is in your free account.
